MyHeart

MyHeart is an Integrated Project aiming to develop intelligent systems for the prevention and monitoring of cardiovascular diseases.The project develops smart electronic and textile systems and appropriate services that empower the users to take control of their own health status.

Cardio-vascular diseases (CVD) are the leading cause of death in developed countries. Roughly 45% of all deaths in the EU are due to cardio-vascular diseases. With the ageing population, it is a challenge for Europe to provide its citizens with healthcare at affordable costs.

It is the aim of the MyHeart project to fight CVD by prevention and early diagnosis. A healthy and preventive lifestyle as well as early diagnosis of heart diseases could save millions of life years annually, reduce the morbidity significantly and, simultaneously, improve the quality of life of the European citizen. Prevention offers the opportunity to systematically fight the origin of cardio-vascular diseases as well as to improve the medical outcome after an event. Classical medical institutions offer only intermittent, episodical treatment, while prevention asks for a lifelong continuous change of habits and therefore for a continuous health-care delivery process. With its innovative system-solutions for integrated textiles, sensors and on-body electronics, the MyHeart project significantly contributes to the European excellence in the area of bioengineering and thereby to the Lisbon strategy of the EC.

For further information, please visit:
http://www.hitech-projects.com/euprojects/myheart/

Project co-ordinator:
Philips GmbH Forschungslaboratorien, GE

Partners:

  • Philips Electronics UK Limited
  • Philips International B.V. – NL
  • Philips Innovative Technology Solutions NV – B
  • Medtronic Iberia SA – E
  • Fundacion Vodafone – E
  • Milior – S.P.A. – I
  • Smartex – S.R.L – I
  • Dr.Hein GMBH – D
  • Medgate AG – CH
  • Centre Suisse D’Electronique et de Microtechnique SA – CH
  • Commissariat à l’énergie Atomique – F
  • Eidgenossische Technische Hochschule Zurich – CH
  • Universita degli Studi di Pisa – I
  • Universidad Politecnica de Madrid – E
  • Instituto de Aplicaciones de las Tecnologías de la Información y de las Comunicaciones Avanzadas - Asociación – E
  • Consorzio di Bioingegneria e Infomatica Medica – I
  • Politecnico di Milano – I
  • Universita’degli studi di Padova (university of Padova) – I
  • Universita degli studi di Firenze – I
  • Universitaetsklinikum Aachen – D
  • Hospital Clinico San Carlos de Madrid Insalud – E
  • Fondazione Centro San Raffaele del Monte Tabor – I
  • Fondazione Salvatore Maugeri Clinica del Lavoro e della Riabilitazione – I
  • Universidad Politecnica de Valencia – E
  • Facludade de ciencias e technologia da universidade de Coimbra – P
  • Hospital de Unisersidate de Coimbra – P
  • Philips Electronics Nederland b.v. – NL
  • Lineapiu S.P.A. – I
  • W. Zimmermann GmbH & Co. KG – D

Timetable: from 01/04 – to 12/08

Total cost: € 34.733.599

EC funding: € 16.000.000

Instrument: IP

Project Identifier: IST-2002-507816

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...